Metabolic Bone Diseases Flashcards

1
Q

Most common metabolic bone disease in the US

A

osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Released from parathyroid in response to low Ca+ level and activate kidney, bones, GI system

A

PTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Released from thyroid in response to elevated serum Ca

A

calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Biggest medication category linked to osteoporosis as a side effect

A

steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Standard test for the evaluation of bone mineral density

A

DEXA scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What age should everyone receive a DEXA scan regardless of risk factors?

A

women > 65 and men > 70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bone mineral density compared to what is normally expected in a young healthy adult (at their peak BMD) based on gender

A

T-score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What T-scare indicates osteroporosis?

A

less than -2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Used in the following populations compared to other ppl of matched ages/sex/race: Premenopausal women, Men younger then 50 years, Children

A

z-score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What z-score is considered “below the expected range for age?”

A

-2.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Effective at predicting femoral neck, hip and spine fractures. Lower cost than DXA. Portable. No exposure to radiation

A

Quantitative calcaneal ultrasonography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What imaging should women btw 65-69 and men btw 75-79 receive if their T-score is -1.5?

A

vertebral imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Symptoms of osteoporosis

A

gradual loss of height and Dowager’s hump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nonpharmacologic treatment of osteoporosis

A

calcium, vit D, excercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which calcium supplement is better when patient is using H2 blockers/PPIs?

A

calcium citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which calcium supplement is less like to cause kidney stones?

A

calcium citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drug of choice for osteoporosis or Paget’s after failure of conservative treatment

A

bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Name the bisphosphonates

A

alendronate (Fosamax), Risedronate (Actonel), Zoledronic acid (Reclast), Ibandronate (Boniva)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Inhibit bone resorption by decreasing the number and function of osteoclasts

A

bisphosphonates

20
Q

What do you need to correct before starting treatment with bisphosphonates?

A

calcium and vitamin D

21
Q

CI to oral bisphosphonates

A

Barretts, upper GI dz, esophagitis, GFR < 35

22
Q

Atypical fractures associated with bisphosphonates

A

subtrochanteric and lateral femur fx

23
Q

Horrifying side effect of bisphosphonates

A

osteonecrosis of jaw

24
Q

How long might you continue therapy for a patient who is high risk (T-score <3.5)?

25
Indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis
Estrogen agonist/antagonist (SERMs)
26
Name the SERM mentioned in Jen's lecture
Raloxifene (Evista)
27
approved for the treatment of osteoporosis in women ≥5 years post menopause. Has not been shown to reduce nonvertebral fractures
calcitonin (miaclcin or fortical)
28
What allergy is a CI to calcitonin treatment?
salmon
29
Only if failed other non-estrogen treatment options. 5 yrs of therapy. Started with 10 yrs of menopause
Hormone replacement therapy (HRT)- Prempro
30
For severe osteoporosis when other treatments have failed. stimulates bone formation also approved for use in men
Parathyroid hormone: Teriparatide (Forteo)
31
Area most commonly involved with Pagets disease
axial skeleton
32
Increased rate of bone remodeling. Overgrowth of bone at single or multiple sites. Impaired integrity of affected bone. Onset after 55
paget's (Osteitis deformans)
33
Cancer associated with Paget's
osteosarcoma
34
Increased lab result with Pagets
alkaline phosphatase
35
Test of choice for Pagets. Show increased bone remodeling and blood flow
bone scan
36
Decreased mineralization of newly formed bone. Bone is soft but no loss of bone matrix
osteomalacia
37
Two main causes of osteomalacia
hypocalcemia and hypophosphatemia
38
Common symptoms of osteomalacia
bone pain, muscle weakness, bone tenderness, fracture
39
Most common imaging finding of osteomalacia
reduced bone density with thinning of the cortex
40
Cortical infarctions wide transverse lucencies traversing bone usually at right angles to the involved cortex. Associated most frequently with osteomalacia and rickets 
Looser's fractures
41
Where are fractures most commonly located in osteomalacia?
distal radius and proximal femur
42
Major contributor to renal osteodystrophy
secondary hyperparathyroidism
43
high turnover secondary to hyperparathyroidism
osteitis fibrosis
44
low turnover, most common CKD related bone disease, due to suppression of the parathyroid glands
adynamic bone disease
45
low turnover with abn mineralization, not that common in CKD
osteomalacia
46
either high or low turnover and abnormal mineralization
mixed osteodystrophy